Kumari Archana, Ranjan Piyush, Chopra Sakshi, Kaur Divjyot, Kaur Tanveer, Upadhyay Ashish Datt, Isaac Joshua Abraham, Kasiraj Rhytha, Prakash Bindu, Kumar Parmeshwar, Dwivedi Sada Nand, Vikram Naval K
Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India.
Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Diabetes Metab Syndr. 2021 May-Jun;15(3):987-992. doi: 10.1016/j.dsx.2021.04.015. Epub 2021 May 1.
The success of the COVID-19 vaccination program is dependent on people's knowledge and attitude regarding the vaccination program. Higher vaccine acceptance can be ensured by strengthening the facilitators and limiting the barriers being observed among the general population.
Indexed study is a cross-sectional web-based survey using a pre-validated questionnaire to assess knowledge, barriers and facilitators of COVID-19 vaccine and vaccination programme administered on adults across India using a Google online survey platform.
A total of 1294 responses (age: 38.02 ± 13.34 years) were collected. Most of the participants had limited knowledge regarding the eligibility of vaccines in vulnerable population groups such as people with allergies (57.89%) and immune-compromised patients (62.98%), pregnant and lactating women (41.89%) and patients with chronic illness (34.78%). Older participants (>45 years) were more willing to take the COVID-19 vaccine (p < 0.001) as they believed the vaccine is not harmful and considered it as societal responsibility. Younger participants (<45 years) and those residing in urban settings raised concerns on the availability of the vaccine and authenticity of the vaccine (p < 0.001).
There is a scope for improvement in people's knowledge regarding COVID-19 vaccine and the vaccination programme by addressing the barriers and facilitators which can improve the participants' turnover at vaccination centres.
2019冠状病毒病疫苗接种计划的成功取决于人们对该接种计划的了解和态度。通过加强促进因素并减少普通人群中观察到的障碍，可以确保更高的疫苗接受度。
本索引研究是一项基于网络的横断面调查，使用经过预验证的问卷，通过谷歌在线调查平台评估印度成年人接种2019冠状病毒病疫苗及接种计划的知识、障碍和促进因素。
共收集到1294份回复（年龄：38.02±13.34岁）。大多数参与者对弱势群体（如过敏人群（57.89%）、免疫功能低下患者（62.98%）、孕妇和哺乳期妇女（41.89%）以及慢性病患者（34.78%））接种疫苗的资格了解有限。年龄较大的参与者（>45岁）更愿意接种2019冠状病毒病疫苗（p<0.001），因为他们认为疫苗无害，并将其视为社会责任。年龄较小的参与者（<45岁）以及居住在城市地区的参与者对疫苗的可及性和疫苗的真实性表示担忧（p<0.001）。
通过解决障碍和促进因素，人们对2019冠状病毒病疫苗及接种计划的了解仍有提升空间，这可以提高接种中心的参与率。
